190 related articles for article (PubMed ID: 33724601)
1. Germline sequence analysis of RABL3 in a large series of pancreatic ductal adenocarcinoma patients reveals no evidence of deleterious variants.
Roberts NJ; Grant RC; Gallinger S; Klein AP;
Genes Chromosomes Cancer; 2021 Aug; 60(8):559-564. PubMed ID: 33724601
[TBL] [Abstract][Full Text] [Related]
2. Mutations in RABL3 alter KRAS prenylation and are associated with hereditary pancreatic cancer.
Nissim S; Leshchiner I; Mancias JD; Greenblatt MB; Maertens O; Cassa CA; Rosenfeld JA; Cox AG; Hedgepeth J; Wucherpfennig JI; Kim AJ; Henderson JE; Gonyo P; Brandt A; Lorimer E; Unger B; Prokop JW; Heidel JR; Wang XX; Ukaegbu CI; Jennings BC; Paulo JA; Gableske S; Fierke CA; Getz G; Sunyaev SR; Wade Harper J; Cichowski K; Kimmelman AC; Houvras Y; Syngal S; Williams C; Goessling W
Nat Genet; 2019 Sep; 51(9):1308-1314. PubMed ID: 31406347
[TBL] [Abstract][Full Text] [Related]
3. Risk of Syndrome-Associated Cancers Among First-Degree Relatives of Patients With Pancreatic Ductal Adenocarcinoma With Pathogenic or Likely Pathogenic Germline Variants.
Chen X; Meyer MA; Kemppainen JL; Horibe M; Chandra S; Majumder S; Petersen GM; Rabe KG
JAMA Oncol; 2023 Jul; 9(7):955-961. PubMed ID: 37200008
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic adenocarcinoma with a germline PTEN p.Arg234Gln mutation.
Uemura S; Matsubayashi H; Kiyozumi Y; Uesaka K; Yamamoto Y; Sasaki K; Abe M; Urakami K; Kusuhara M; Yamaguchi K
Fam Cancer; 2018 Apr; 17(2):255-259. PubMed ID: 28755079
[TBL] [Abstract][Full Text] [Related]
5. Novel Models of Genetic Education and Testing for Pancreatic Cancer Interception: Preliminary Results from the GENERATE Study.
Furniss CS; Yurgelun MB; Ukaegbu C; Constantinou PE; Lafferty CC; Talcove-Berko ER; Schwartz AN; Stopfer JE; Underhill-Blazey M; Kenner B; Nelson SH; Okumura S; Law S; Zhou AY; Coffin TB; Rodriguez NJ; Uno H; Ocean AJ; McAllister F; Lowy AM; Lippman SM; Klein AP; Madlensky L; Petersen GM; Garber JE; Goggins MG; Maitra A; Syngal S
Cancer Prev Res (Phila); 2021 Nov; 14(11):1021-1032. PubMed ID: 34625409
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic Features and Germline Sequence Variants in Young Patients (≤40 Years Old) With Pancreatic Ductal Adenocarcinoma.
Ohmoto A; Yachida S; Kubo E; Takai E; Suzuki M; Shimada K; Okusaka T; Morizane C
Pancreas; 2016 Aug; 45(7):1056-61. PubMed ID: 26692440
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of Germline Sequence Variations Among Patients With Pancreatic Cancer in China.
Yin L; Wei J; Lu Z; Huang S; Gao H; Chen J; Guo F; Tu M; Xiao B; Xi C; Zhang K; Li Q; Wu J; Gao W; Jiang K; Yu J; Miao Y
JAMA Netw Open; 2022 Feb; 5(2):e2148721. PubMed ID: 35171259
[TBL] [Abstract][Full Text] [Related]
8. Burden of hereditary cancer susceptibility in unselected patients with pancreatic ductal adenocarcinoma referred for germline screening.
Cremin C; Lee MK; Hong Q; Hoeschen C; Mackenzie A; Dixon K; McCullum M; Nuk J; Kalloger S; Karasinska J; Scudamore C; Kim PTW; Donnellan F; Lam ECS; Lim HJ; Neben CL; Stedden W; Zhou AY; Schaeffer DF; Sun S; Renouf DJ; Schrader KA
Cancer Med; 2020 Jun; 9(11):4004-4013. PubMed ID: 32255556
[TBL] [Abstract][Full Text] [Related]
9. Association of Germline Variants in Human DNA Damage Repair Genes and Response to Adjuvant Chemotherapy in Resected Pancreatic Ductal Adenocarcinoma.
Hu H; Zhu Y; Pu N; Burkhart RA; Burns W; Laheru D; Zheng L; He J; Goggins MG; Yu J
J Am Coll Surg; 2020 Nov; 231(5):527-535.e14. PubMed ID: 32659497
[TBL] [Abstract][Full Text] [Related]
10. Functional CDKN2A assay identifies frequent deleterious alleles misclassified as variants of uncertain significance.
Kimura H; Paranal RM; Nanda N; Wood LD; Eshleman JR; Hruban RH; Goggins MG; Klein AP; ; Roberts NJ
Elife; 2022 Jan; 11():. PubMed ID: 35001868
[TBL] [Abstract][Full Text] [Related]
11. The Role of Inherited Pathogenic CDKN2A Variants in Susceptibility to Pancreatic Cancer.
Kimura H; Klein AP; Hruban RH; Roberts NJ
Pancreas; 2021 Sep; 50(8):1123-1130. PubMed ID: 34714275
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and Risk Factors of Germline Pathogenic Variants in Pancreatic Ductal Adenocarcinoma.
Ryu KH; Park S; Chun JW; Cho E; Choi J; Lee DE; Shim H; Kim YH; Han SS; Park SJ; Woo SM; Kong SY
Cancer Res Treat; 2023 Oct; 55(4):1303-1312. PubMed ID: 37024097
[TBL] [Abstract][Full Text] [Related]
13. Prospective study of germline genetic testing in incident cases of pancreatic adenocarcinoma.
Brand R; Borazanci E; Speare V; Dudley B; Karloski E; Peters MLB; Stobie L; Bahary N; Zeh H; Zureikat A; Hogg M; Lee K; Tsung A; Rhee J; Ohr J; Sun W; Lee J; Moser AJ; DeLeonardis K; Krejdovsky J; Dalton E; LaDuca H; Dolinsky J; Colvin A; Lim C; Black MH; Tung N
Cancer; 2018 Sep; 124(17):3520-3527. PubMed ID: 30067863
[TBL] [Abstract][Full Text] [Related]
14. Deleterious Germline Mutations Are a Risk Factor for Neoplastic Progression Among High-Risk Individuals Undergoing Pancreatic Surveillance.
Abe T; Blackford AL; Tamura K; Ford M; McCormick P; Chuidian M; Almario JA; Borges M; Lennon AM; Shin EJ; Klein AP; Hruban RH; Canto MI; Goggins M
J Clin Oncol; 2019 May; 37(13):1070-1080. PubMed ID: 30883245
[TBL] [Abstract][Full Text] [Related]
15. Genetic assessment of pathogenic germline alterations in lysosomal genes among Asian patients with pancreatic ductal adenocarcinoma.
Koh Y; Kim H; Joo SY; Song S; Choi YH; Kim HR; Moon B; Byun J; Hong J; Shin DY; Park S; Lee KH; Lee KT; Lee JK; Park D; Lee SH; Jang JY; Lee H; Kim JA; Yoon SS; Park JK
J Transl Med; 2023 Oct; 21(1):730. PubMed ID: 37848935
[TBL] [Abstract][Full Text] [Related]
16. Whole genome sequencing identifies rare germline variants enriched in cancer related genes in first degree relatives of familial pancreatic cancer patients.
Tan M; Brusgaard K; Gerdes AM; Mortensen MB; Detlefsen S; Schaffalitzky de Muckadell OB; Joergensen MT
Clin Genet; 2021 Nov; 100(5):551-562. PubMed ID: 34313325
[TBL] [Abstract][Full Text] [Related]
17. The Evolving Paradigm of Germline Testing in Pancreatic Ductal Adenocarcinoma and Implications for Clinical Practice.
Mohindroo C; De Jesus-Acosta A; Yurgelun MB; Maitra A; Mork M; McAllister F
Surg Pathol Clin; 2022 Sep; 15(3):491-502. PubMed ID: 36049831
[TBL] [Abstract][Full Text] [Related]
18. Germline BRCA Mutations in a Large Clinic-Based Cohort of Patients With Pancreatic Adenocarcinoma.
Holter S; Borgida A; Dodd A; Grant R; Semotiuk K; Hedley D; Dhani N; Narod S; Akbari M; Moore M; Gallinger S
J Clin Oncol; 2015 Oct; 33(28):3124-9. PubMed ID: 25940717
[TBL] [Abstract][Full Text] [Related]
19. Germline variants in cancer-predisposing genes in pancreatic cancer patients with a family history of cancer.
Terashima T; Morizane C; Ushiama M; Shiba S; Takahashi H; Ikeda M; Mizuno N; Tsuji K; Yasui K; Azemoto N; Satake H; Nomura S; Yachida S; Sugano K; Furuse J
Jpn J Clin Oncol; 2022 Oct; 52(10):1105-1114. PubMed ID: 36135357
[TBL] [Abstract][Full Text] [Related]
20. Germline mutations in homologous recombination repair genes among Chinese pancreatic ductal adenocarcinoma patients detected using next-generation sequencing.
Jiang H; Huang F; Chen X; Zhang L; Shen M; Pan B; Wang B; Guo W
Mol Genet Genomic Med; 2023 Jul; 11(7):e2170. PubMed ID: 36978154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
